Article
ESR1 polymorphisms and statin therapy: a sex-specific approach.
The pharmacogenomics journal - 1 Nov 2016
Smiderle L, Fiegenbaum M, Hutz M H, Van Der Sand C R, Van Der Sand L C, Ferreira M E W, Pires R C, Almeida S
Abstract excerpt
Lipid-lowering therapy has shown a high degree of variability in clinical response and there is evidence that the variability in drug response between individuals is due to genetic factors. Thirteen single nucleotide polymorphisms (SNPs) within the ESR1 gene were evaluated with basal lipid and lipoprotein levels, as well as response to lipid-lowering therapy, in 495 hypercholesterolemic individuals of European...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
